SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Oncolytics Biotech Inc. Completes Patient Enrollment in U.S. Phase 2 Study of REOLYSIN® in Non-Small Cell Lung Cancer